Literature DB >> 21126840

Analysis of left atrial appendix by dual-source CT coronary angiography: morphologic classification and imaging by volume rendered CT images.

Bekir Erol1, Musturay Karcaaltincaba, Kudret Aytemir, Nurdan Cay, Tuncay Hazirolan, Deniz Akata.   

Abstract

AIM: We investigated the evaluability of left atrial appendix by dual source coronary CT angiography and analyzed morphologic features.
MATERIALS AND METHODS: We included 106 consecutive patients who underwent coronary CT angiography for various indications. Technical parameters were slice thickness 0.6 mm, reconstruction interval 0.3mm, gantry rotation time 165 ms. Images were reconstructed from 10% to 100% R-R intervals at 10% intervals to evaluate the left atrial appendix and 4-D inspace software was used for analysis. We recorded the R-R intervals when the left atrial appendix was at maximum and minimum volume. We also evaluated visibility of appendix at R-R intervals. Maximum appendix volume was calculated. Atrial appendices were classified morphologically based on number of chambers (types 1-3) seen on volume rendered images.
RESULTS: There were 60 male and 46 female patients in the study group and, mean age was 55±13. Mean heart rate was 72 (ranges 47-110). Left atrial was evaluable at maximum and minimum volume by coronary CT angiography in all patients. We noted types 1-3 appendix in 29 (27%), 73 (69%), and 4 (4%) patients, respectively. Mean R-R intervals at maximum and minimum volume were 40%±6 (95% CI; 28-52%) and 95%±5 (95% CI; 85-5%), respectively. Mean appendix maximum volume was 7±4 cm3. Appendix contours were mildly, moderately and severely irregular in 10 (9%), 58 (55%), 38 (36%) patients, respectively.
CONCLUSION: Left atrial appendix was visualized in all patients independent of heart rate at maximum and minimum volumes. Volume rendered CT images can allow excellent depiction of left atrial appendix morphology and classification. Presence of moderate and severe irregularity of appendix contour in most of the patients may be the cause of slow flow. This morphologic appearance may be the underlying reason for the propensity to atrial appendix thrombus formation.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21126840     DOI: 10.1016/j.ejrad.2010.11.008

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  5 in total

Review 1.  Preprocedural imaging for patients with atrial fibrillation and heart failure.

Authors:  Wai-ee Thai; Bryan Wai; Quynh A Truong
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

Review 2.  Role of cardiac computed tomography and cardiovascular magnetic resonance imaging in guiding management and treatment of patients with atrial fibrillation: state of the art review.

Authors:  Wael A Aljaroudi; Walid S Saliba; Oussama M Wazni; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2013-02-12       Impact factor: 5.952

3.  3D-computed tomography to compare the dimensions of the left atrial appendage in patients with normal sinus rhythm and those with paroxysmal atrial fibrillation.

Authors:  Maiko Hozawa; Yoshihiro Morino; Yuki Matsumoto; Ryoichi Tanaka; Kyohei Nagata; Akiko Kumagai; Atsushi Tashiro; Akio Doi; Kunihiro Yoshioka
Journal:  Heart Vessels       Date:  2018-01-12       Impact factor: 2.037

4.  Morphological and volumetric analysis of left atrial appendage and left atrium: cardiac computed tomography-based reproducibility assessment.

Authors:  Mikko Taina; Miika Korhonen; Mika Haataja; Antti Muuronen; Otso Arponen; Marja Hedman; Pekka Jäkälä; Petri Sipola; Pirjo Mustonen; Ritva Vanninen
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

5.  Left atrial appendage morphology in patients with suspected cardiogenic stroke without known atrial fibrillation.

Authors:  Miika Korhonen; Antti Muuronen; Otso Arponen; Pirjo Mustonen; Marja Hedman; Pekka Jäkälä; Ritva Vanninen; Mikko Taina
Journal:  PLoS One       Date:  2015-03-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.